Checked.be
Active
BE 0727.868.303Private limited company
MASSS
Kouterlaan 7 ·1930 Zaventem, Belgium· 7 yrs active
Sector: Dental practice
(86230)
Conclusion
MASSS has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €21k and a net result of €978. Equity is growing by ~81.6% per year across the filed fiscal years. Its solvency ranks better than 60% of 90 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €21k |
| Net result | €978 |
| Better than sector | 60% |
| Active | 7 yrs |
Financial profile
74
/ 100
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Health
71
Profitability
23
Solvency
100
Growth
78
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2019, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
71
/ 100
Healthy
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€2k
estimate, not credit advice
Score history
43
2022
13
2023
100
2024
71
2025
purely financial, excl. current insolvency signals
Score components
Leverage
Debt/equity 0.53 (< 1.0)
+10
Profitability
ROE 5%
+3
Interest coverage
Interest coverage 155.4× (≥ 3×)
+8
Profit trend
Net profit down YoY
-3
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 31-08-2026 with the NBB · fiscal year 2025 · abbreviated schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~81.6%/year over 4 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 65.3% | 56.8% | |
| Net result | €978 | €93k | |
| Equity | €21k | €202k | |
| Gross operating margin | €10k | €237k | |
| Total assets | €33k | €596k |
€9k
-77.8%
22-25
€978
-96.4%
22-25
€8k
-75.9%
22-25
€33k
-16.0%
22-25
€21k
+4.8%
22-25
€3k
-
22-25
€954
-87.0%
22-25
€11k
-38.8%
22-25
€4k
-
22-25
€11k
-20.4%
22-25
1.73
-
22-25
1.73
-
22-25
65.3%
+24.7%
22-25
0.53
-41.6%
22-25
4.6%
-96.6%
22-25
3.0%
-95.8%
22-25
155.36
-77.2%
22-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Deposit | abbreviated schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | €9k | €42k | €11k | €667 |
| Net profit | €978 | €27k | €3k | €-9k |
| Cash flow | €8k | €35k | €11k | €569 |
| Staff costs | - | - | - | - |
| Income taxes | €954 | €7k | - | - |
| Dividends | - | - | - | - |
| Total assets | €33k | €39k | €39k | €36k |
| Equity | €21k | €20k | €-7k | €-10k |
| Debt | €11k | €19k | €46k | €46k |
| of which ≤ 1y | - | €4k | - | - |
| of which > 1y | €11k | €14k | €46k | €46k |
| Working capital | - | €3k | - | - |
| Employees (FTE) | - | - | - | - |
Note: these years are not on the same basis. The filed schemas differ (abbreviated schema, micro schema), so the columns are not directly comparable.
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current ratio | - | 1.73 | - | - |
| Quick ratio | - | 1.73 | - | - |
| Working capital ratio | - | 8.1% | - | - |
| Solvency | 65.3% | 52.3% | -18.2% | -26.9% |
| Debt / equity | 0.53 | 0.91 | -6.50 | -4.72 |
| Long-term debt ratio | 0.53 | 0.70 | -6.50 | -4.72 |
| Interest coverage | 155.36 | 681.42 | -65.24 | 6.67 |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | 3.0% | 70.4% | 6.9% | -23.8% |
| ROE | 4.6% | 134.6% | -37.7% | 88.4% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (22 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €33k | €39k | €39k | €36k |
| Fixed assets | 21/28 | €24k | €32k | €27k | €35k |
| Tangible fixed assets | 22/27 | €24k | €32k | €27k | €35k |
| Current assets | 29/58 | €9k | €7k | €12k | €690 |
| Amounts receivable within one year | 40/41 | €4k | - | - | - |
| Cash & bank | 54/58 | €1 | €3k | €5k | €67 |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €33k | €39k | €39k | €36k |
| Equity | 10/15 | €21k | €20k | €-7k | €-10k |
| Contributions / capital | 10/11 | €6k | €6k | €6k | €6k |
| Accumulated profits (losses) | 14 | €15k | €14k | €-13k | €-16k |
| Amounts payable | 17/49 | €11k | €19k | €46k | €46k |
| Amounts payable after one year | 17 | €11k | €14k | €46k | €46k |
| Amounts payable within one year | 42/48 | - | €4k | - | - |
| Trade debts payable within one year | 44 | - | €976 | - | - |
| Income statement | |||||
| Gross operating margin | 9900 | €10k | €44k | €11k | €1k |
| Operating result | 9901 | €2k | €35k | €2k | €-8k |
| Financial income | 75 | - | - | - | €2 |
| Financial charges | 65 | €60 | €62 | €-165 | €100 |
| Result before taxes | 9903 | €2k | €35k | €3k | €-9k |
| Income taxes | 67/77 | €954 | €7k | - | - |
| Net result for the period | 9904 | €978 | €27k | €3k | €-9k |
| Result to be appropriated | 9905 | €978 | €27k | €3k | €-9k |
Legal Structure
| NACE primary | Dental practice(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 07-06-2019 |
| Status | Active |
| Postal code | 1930 |
Establishment units
MASSS
since 20192.301.599.964
Real-estate footprint
Flanders
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23772C0251/00R009 | Flanders | 1,151 m² | 1 · 212 m² | 9.0 m · 2 fl. |
| 21522B0237/00K005 | Brussels | 89 m² | 1 · 88 m² | 16.3 m · 3 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Highest result since 2022net €27k ▲932%
Operating result €35k, net result €27k, both a record.
27-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 27 days late
2023
31-12
Financial
Back to profitnet €3k
Net result €3k after one loss-making year.
17-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
23-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 23 days late
2021
24-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Dental practice86230
Names & trade names
| Legal nameNL | MASSS |
Similar companies
JULABEL
BE 0567.640.832 · Ottignies-Louvain-la-Neuve
JSoubhi SRL
BE 0745.494.686 · Beyne-Heusay
BOCHICO
BE 0805.131.870 · Ham-sur-Heure-Nalinnes
HD DENTAL
BE 0658.734.720 · Charleroi
DENTAPROTHÈSE
BE 0749.522.265 · Namur